Population pharmacokinetic approach to the use of low dose cyclosporine in patients with connective tissue diseases

Yasuhiro Tsuji, Nozomi Iwanaga, Akiko Mizoguchi, Emi Sonemoto, Yoichi Hiraki, Yukio Ota, Hidefumi Kasai, Eiji Yukawa, Yukitaka Ueki, Hideto To

研究成果: Article査読

3 被引用数 (Scopus)

抄録

This study describes the population pharmacokinetics and dose personalization of cyclosporine in 36 patients with connective tissue diseases. A one-compartment open model with absorption was adopted as a pharmacokinetic model, and a nonlinear mixed effects model was used to analyze the population pharmacokinetic models. In the final model, age (AGE) and total body weight (TBW) were influential covariates on clearance (CL/F), which was expressed as CL/F (L/h)=17.8×(AGE/60)-0.269×(TBW/46.9)0.408, in addition to the volume of distribution (Vd/F), (L)=98.0 and absorption rate constant (Ka) (h-1)=0.67 (fixed). The results of the present study provide novel insights into factors involved in determining the most suitable dose and dosing strategy for individual patients with connective tissue disease.

本文言語English
ページ(範囲)1265-1271
ページ数7
ジャーナルBiological and Pharmaceutical Bulletin
38
9
DOI
出版ステータスPublished - 2015 9 1
外部発表はい

ASJC Scopus subject areas

  • 薬理学
  • 薬科学

フィンガープリント

「Population pharmacokinetic approach to the use of low dose cyclosporine in patients with connective tissue diseases」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル